國立高雄大學圖資館 |

登入

回首頁

Actinobacteriamicrobiology to synthetic biology /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Actinobacteriaedited by Loganathan Karthik.
其他題名:	microbiology to synthetic biology /
其他作者:	Karthik, Loganathan.
出版者:	Singapore :Springer Singapore :2022.
面頁冊數:	xv, 276 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Actinobacteria.
電子資源:	https://doi.org/10.1007/978-981-16-5835-8
ISBN:	9789811658358$q(electronic bk.)

Actinobacteriamicrobiology to synthetic biology /
Actinobacteriamicrobiology to synthetic biology /[electronic resource] :edited by Loganathan Karthik. - Singapore :Springer Singapore :2022. - xv, 276 p. :ill., digital ;24 cm.

Chapter 1. Actinomycetes: Microbiology to Systems Biology -- Chapter 2. Diversity of actinobacteria in various habitats -- Chapter 3. Traditional Screening and Genome Guided Screening of Natural Products from Actinobacteria -- Chapter 4. The relationship between actinobacteria and rice -- Chapter 5.Non-ribosomally and ribosomally synthesized bioactive peptides - NRPS and RiPPs from actinobacteria -- Chapter 6. Genome Data Mining, Chemistry and Bioactivity of Sesquiterpenes from Actinobacteria -- Chapter 7. Genome Data Mining, Chemistry and Bioactivity of Sesquiterpenes from Actinobacteria -- Chapter 8. Cloning and Heterologous expression of Natural products from Actinobacteria -- Chapter 9. Synthetic Biology and Metabolic Engineering in Actinobacteria for Natural Product Production -- Chapter 10. CRISPR ERA: CURRENT APPLICATIONS AND FUTURE PERSPECTIVES ON ACTINOBACTERIA -- Chapter 11. Uncultured Actinobacteria and Reverse engineering and Artificial Intelligence role in future -- Chapter 12. Cultivation and Diversity of Marine Actinomycetes: Molecular Approaches and Bioinformatics Tools -- Chapter 13. Antimicrobial Potential and Metabolite Profiling of Marine Actinobacteria -- Chapter 14. Pharmacology of FDA Approved Medicines from Actinobacteria.

This book summarizes the basics of actinobacteria, from microbiology to synthetic biology. It focuses on diversity, NRPS, sesquiterpenes, lantipeptide, bioinformatics apparatuses, cloning, CRISPR, reverse engineering, FDA supported medications, and marine actinobacteria. It also covers the latest trends in drug discovery from actinobacteria, and introduces several recently developed bioinformatics and synthetic biology tools to explore new antibiotics from actinobacteria. Many natural products such as polyketides, isoprenoids, phenazines, peptides, indolocarbarbazoles, sterols, and others have been isolated and characterized from actinobacteria. Some products are synthesized by the non-ribosomal peptide synthetases (NRPSs), polyketide synthases (PKSs), or other functional genes. Although genome sequencing has uncovered the differing qualities of these chemicals, recognizing new items and their biosynthetic pathways is still under examination. Cryptic metabolic pathways have been explored using molecular techniques or culture-dependent approaches. In recent years, researchers' primary interest is to identify the specific conditions or agents that wake the cryptic antibiotics. Several bioinformatics and synthetic biology tools were developed to explore new antibiotics from actinobacteria. The book comprises 14 chapters with different aspects of application and utilization of actinomycetes from the microbiology; systems biology, pharmacology of natural products, bioinformatics, actinomycete and its diversity, CRISPR, artificial Intelligence, synthetic biology, metabolic engineering, expressional studies, and biosynthetic gene clusters. The book delivers useful information on actinomyces to researchers, novices in genome designing, specialists, clinicians, policymakers, and professionals.

ISBN: 9789811658358$q(electronic bk.)

Standard No.: 10.1007/978-981-16-5835-8doiSubjects--Topical Terms:

711695
Actinobacteria.

LC Class. No.: QR82.A35 / A37 2022

Dewey Class. No.: 579.3

Actinobacteriamicrobiology to synthetic biology /
LDR:04077nmm a2200325 a 4500 001 618769
003 DE-He213
005 20220129131652.0
006 m d
007 cr nn 008maaau
008 221103s2022 si s 0 eng d
020 $a 9789811658358$q(electronic bk.)
020 $a 9789811658341$q(paper)
024 7 $a 10.1007/978-981-16-5835-8 $2 doi
035 $a 978-981-16-5835-8
040 $a GP $c GP
041 0 $a eng
050 4 $a QR82.A35 $b A37 2022
072 7 $a PSB $2 bicssc
072 7 $a SCI010000 $2 bisacsh
072 7 $a PSE $2 thema
082 0 4 $a 579.3 $2 23
090 $a QR82.A35 $b A188 2022
245 0 0 $a Actinobacteria $h [electronic resource] : $b microbiology to synthetic biology / $c edited by Loganathan Karthik.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2022.
300 $a xv, 276 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Actinomycetes: Microbiology to Systems Biology -- Chapter 2. Diversity of actinobacteria in various habitats -- Chapter 3. Traditional Screening and Genome Guided Screening of Natural Products from Actinobacteria -- Chapter 4. The relationship between actinobacteria and rice -- Chapter 5.Non-ribosomally and ribosomally synthesized bioactive peptides - NRPS and RiPPs from actinobacteria -- Chapter 6. Genome Data Mining, Chemistry and Bioactivity of Sesquiterpenes from Actinobacteria -- Chapter 7. Genome Data Mining, Chemistry and Bioactivity of Sesquiterpenes from Actinobacteria -- Chapter 8. Cloning and Heterologous expression of Natural products from Actinobacteria -- Chapter 9. Synthetic Biology and Metabolic Engineering in Actinobacteria for Natural Product Production -- Chapter 10. CRISPR ERA: CURRENT APPLICATIONS AND FUTURE PERSPECTIVES ON ACTINOBACTERIA -- Chapter 11. Uncultured Actinobacteria and Reverse engineering and Artificial Intelligence role in future -- Chapter 12. Cultivation and Diversity of Marine Actinomycetes: Molecular Approaches and Bioinformatics Tools -- Chapter 13. Antimicrobial Potential and Metabolite Profiling of Marine Actinobacteria -- Chapter 14. Pharmacology of FDA Approved Medicines from Actinobacteria.
520 $a This book summarizes the basics of actinobacteria, from microbiology to synthetic biology. It focuses on diversity, NRPS, sesquiterpenes, lantipeptide, bioinformatics apparatuses, cloning, CRISPR, reverse engineering, FDA supported medications, and marine actinobacteria. It also covers the latest trends in drug discovery from actinobacteria, and introduces several recently developed bioinformatics and synthetic biology tools to explore new antibiotics from actinobacteria. Many natural products such as polyketides, isoprenoids, phenazines, peptides, indolocarbarbazoles, sterols, and others have been isolated and characterized from actinobacteria. Some products are synthesized by the non-ribosomal peptide synthetases (NRPSs), polyketide synthases (PKSs), or other functional genes. Although genome sequencing has uncovered the differing qualities of these chemicals, recognizing new items and their biosynthetic pathways is still under examination. Cryptic metabolic pathways have been explored using molecular techniques or culture-dependent approaches. In recent years, researchers' primary interest is to identify the specific conditions or agents that wake the cryptic antibiotics. Several bioinformatics and synthetic biology tools were developed to explore new antibiotics from actinobacteria. The book comprises 14 chapters with different aspects of application and utilization of actinomycetes from the microbiology; systems biology, pharmacology of natural products, bioinformatics, actinomycete and its diversity, CRISPR, artificial Intelligence, synthetic biology, metabolic engineering, expressional studies, and biosynthetic gene clusters. The book delivers useful information on actinomyces to researchers, novices in genome designing, specialists, clinicians, policymakers, and professionals.
650 0 $a Actinobacteria. $3 711695
650 1 4 $a Synthetic Biology. $3 667902
650 2 4 $a Bioinformatics. $3 194415
650 2 4 $a Drug Delivery. $3 911847
650 2 4 $a Industrial Microbiology. $3 229943
700 1 $a Karthik, Loganathan. $3 918711
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-16-5835-8
950 $a Biomedical and Life Sciences (SpringerNature-11642)